Evidence map›Paper›PMID 39070184›Full record

ArticleBiology methods & protocols2024

High-throughput surface epitope immunoaffinity isolation of extracellular vesicles and downstream analysis.

Ramin Khanabdali, Michelle Mandrekar, Rick Grygiel, Phuoc-An Vo, Carlos Palma, Sara Nikseresht, Siena Barton, Mozhgan Shojaee, Sadman Bhuiyan, Kartini Asari and 12 more

Abstract read
In one paragraph

Article in Biology methods & protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Extracellular vesicles: Navigating new frontiers in glioblastoma therapy.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Ramin KhanabdaliINOVIQ Ltd., Notting Hill, VIC 3168, Australia.ORCID https://orcid.org/0009-0002-1150-2009
Michelle MandrekarPromega Corporation, Madison, WI 53711, United States.
Rick GrygielPromega Corporation, Madison, WI 53711, United States.
Phuoc-An VoPromega Corporation, Madison, WI 53711, United States.
Carlos PalmaINOVIQ Ltd., Notting Hill, VIC 3168, Australia.
Sara NiksereshtINOVIQ Ltd., Notting Hill, VIC 3168, Australia.
Siena BartonINOVIQ Ltd., Notting Hill, VIC 3168, Australia.
Mozhgan ShojaeeINOVIQ Ltd., Notting Hill, VIC 3168, Australia.
Sadman BhuiyanINOVIQ Ltd., Notting Hill, VIC 3168, Australia.
Kartini AsariINOVIQ Ltd., Notting Hill, VIC 3168, Australia.
Susan BelzerINOVIQ Ltd., Notting Hill, VIC 3168, Australia.
Khairul AnsariINOVIQ Ltd., Notting Hill, VIC 3168, Australia.
Jermaine I CowardMater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
Lewis PerrinMater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
John HooperMater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.
Dominic GuanzonTranslational Extracellular Vesicles in Obstetrics and Gynae-Oncology Group, UQ Centre for Clinical Research, Royal Brisbane and Women's Hospital, Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Andrew LaiTranslational Extracellular Vesicles in Obstetrics and Gynae-Oncology Group, UQ Centre for Clinical Research, Royal Brisbane and Women's Hospital, Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Carlos SalomonTranslational Extracellular Vesicles in Obstetrics and Gynae-Oncology Group, UQ Centre for Clinical Research, Royal Brisbane and Women's Hospital, Faculty of Medicine, The University of Queensland, Brisbane, Australia.ORCID https://orcid.org/0000-0003-4474-0046
Kevin KershnerPromega Corporation, Madison, WI 53711, United States.
Christine NewtonPromega Corporation, Madison, WI 53711, United States.
Douglas HorejshPromega Corporation, Madison, WI 53711, United States.
Gregory RiceINOVIQ Ltd., Notting Hill, VIC 3168, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular vesicles (EVs), including exosomes, have significant potential for diagnostic and therapeutic applications. The lack of standardized methods for efficient and high-throughput isolation and analysis of EVs, however, has limited their widespread use in clinical practice. Surface epitope immunoaffinity (SEI) isolation utilizes affinity ligands, including antibodies, aptamers, or lectins, that target specific surface proteins present on EVs. Paramagnetic bead-SEI isolation represents a fit-for-purpose solution for the reproducible, high-throughput isolation of EVs from biofluids and downstream analysis of RNA, protein, and lipid biomarkers that is compatible with clinical laboratory workflows. This study evaluates a new SEI isolation method for enriching subpopulations of EVs. EVs were isolated from human plasma using a bead-based SEI method designed for on-bead and downstream analysis of EV-associated RNA and protein biomarkers. Western blot analysis confirmed the presence of EV markers in the captured nanoparticles. Mass spectrometry analysis of the SEI lysate identified over 1500 proteins, with the top 100 including known EV-associated proteins. microRNA (miRNA) sequencing followed by RT-qPCR analysis identified EV-associated miRNA transcripts. Using SEI, EVs were isolated using automated high-throughput particle moving instruments, demonstrating equal or higher protein and miRNA yield and recovery compared to manual processing. SEI is a rapid, efficient, and high-throughput method for isolating enriched populations of EVs; effectively reducing contamination and enabling the isolation of a specific subpopulation of EVs. In this study, high-throughput EV isolation and RNA extraction have been successfully implemented. This technology holds great promise for advancing the field of EV research and facilitating their application for biomarker discovery and clinical research.

Indexed as

EV RNA and protein isolationExosomesExtracellular vesicles (EVs)High-throughputImmunoaffinity

Identifiers

PMID39070184
PMCPMC11272960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.